Recurrent vulvovaginal candidiasis (RVVC) is a common cause of significant morbidity in
women in all strata of society affecting millions of women worldwide. Previously, RVVC …

Methods This systematic review was conducted by searching the major databases, such as
Google Scholar, Emerald, Science Direct, Web of Science, Pubmed, and Scopus. We used …

Objective To review the evidence and provide recommendations on screening for and
management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. Outcomes …

Recurrent vulvovaginal candidosis (RVVC) is a chronic, difficult to treat vaginal infection,
caused by Candida species, which affects women of all ages and ethnic and social …

Approximately three-quarters of all women will experience an episode of vulvovaginal
candidosis at least once in their life and 5-10% of them will have more than one attack …

The treatment of vulvovaginal candidiasis (VVC) due to Candida glabrata is challenging,
with limited therapeutic options. Unexplained disappointing clinical efficacy has been …

When it comes to women's health, treating vaginal infections makes up a high proportion of
the gynecological services. Among the forms of vaginitis, vulvovaginal candidiasis (VVC) is …

Background Recurrent vulvovaginal candidiasis (VVC) is a difficult‐to‐manage condition
that affects 5–8% of women of reproductive age. Current treatment regimes have high …

Patients with diabetes, especially those with poorly controlled glycemia, are prone to
developing genital mycotic infections—vulvovaginal candidiasis in women and Candida …

OBJECTIVE: To estimate the effects of vaginal pH-balanced gel on vaginal symptoms and
atrophy in breast cancer survivors treated with chemotherapy or endocrine therapy …